Opdenakker G, Van Damme J
Cytokine Growth Factor Rev. 2021; 58:134-140.
PMID: 33563543
PMC: 7845543.
DOI: 10.1016/j.cytogfr.2021.01.004.
Wells A, Coyne C
Viruses. 2019; 11(5).
PMID: 31117206
PMC: 6563291.
DOI: 10.3390/v11050460.
Hedley-Whyte J, Milamed D
Ulster Med J. 2019; 88(1):47-54.
PMID: 30675080
PMC: 6342045.
Sanders B, de Los Rios Oakes I, van Hoek V, Bockstal V, Kamphuis T, Uil T
PLoS Pathog. 2016; 12(3):e1005483.
PMID: 27032093
PMC: 4816566.
DOI: 10.1371/journal.ppat.1005483.
Wieland S
Cold Spring Harb Perspect Med. 2015; 5(6).
PMID: 26033082
PMC: 4448699.
DOI: 10.1101/cshperspect.a021469.
Characterization of Poliovirus Neutralization Escape Mutants of Single-Domain Antibody Fragments (VHHs).
Schotte L, Thys B, Strauss M, Filman D, Rombaut B, Hogle J
Antimicrob Agents Chemother. 2015; 59(8):4695-706.
PMID: 26014941
PMC: 4505203.
DOI: 10.1128/AAC.00878-15.
THE BEHAVIOUR OF ATTENUATED STRAINS OF POLIOVIRUS IN MONKEYS.
BESWICK T, Coid C, HARTLEY E, Henderson M, Winter M
J Neurol Neurosurg Psychiatry. 1964; 27:10-24.
PMID: 14123918
PMC: 495660.
DOI: 10.1136/jnnp.27.1.10.
Immunological response to trivalent oral poliomyelitis vaccine.
COX H, CABASSO V, Markham F, MOSES M, MOYER A, ROCA-GARCIA M
Br Med J. 1959; 2(5152):591-7.
PMID: 13812518
PMC: 1990089.
DOI: 10.1136/bmj.2.5152.591.
Factors influencing the occurrence of illness during naturally acquired polimyelitis virus infections.
Evans C
Bacteriol Rev. 1960; 24(4):341-52.
PMID: 13697553
PMC: 441061.
DOI: 10.1128/br.24.4.341-352.1960.
Discussion on poliomyelitis vaccination in 1956.
Stuart-Harris C
Proc R Soc Med. 1957; 50(12):1067-8.
PMID: 13494515
PMC: 1889479.
Poliomyelitis: problems in pathogenesis and immunization.
Horstmann D
Yale J Biol Med. 1957; 30(2):81-100.
PMID: 13486799
PMC: 2603686.
Infection induced by oral administration of attenuated poliovirus to persons possessing homotypic antibody.
Horstmann D, Paul J, Melnick J, Deutsch J
J Exp Med. 1957; 106(1):159-77.
PMID: 13439122
PMC: 2136730.
DOI: 10.1084/jem.106.1.159.
SAFETY and antigenic potency testing of poliomyelitis vaccine; a report from the Biological Standards Control Laboratory, Medical Research Council Laboratories, London, N.W.3.
Br Med J. 1957; 2(5037):124-6.
PMID: 13436874
PMC: 1961861.
ANTIGENIC activity of British poliomyelitis vaccine; a report to the committee on laboratory investigations of poliomyelitis of the Medical Research Council.
Br Med J. 1957; 1(5015):366-8.
PMID: 13396260
PMC: 1974332.
Properties of an ideal poliomyelitis vaccine.
Paul J
Bull N Y Acad Med. 1956; 32(10):747-52.
PMID: 13364585
PMC: 1806014.
